Wells Fargo & Company Lantern Pharma Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 7,058 shares of LTRN stock, worth $22,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,058

Previous 7,616 7.33%

Holding current value

$22,797

Previous $67,000 52.24%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.91 - $9.51 $2,181 - $5,306	-558 Reduced 7.33%	7,058 $32,000
Q1 2024 May 10, 2024	BUY	$3.73 - $10.65 $11,641 - $33,238	3,121 Added 69.43%	7,616 $67,000
Q4 2023 Feb 09, 2024	BUY	$2.48 - $4.39 $7 - $13	3 Added 0.07%	4,495 $19,000
Q3 2023 Nov 13, 2023	BUY	$3.41 - $5.51 $13 - $22	4 Added 0.09%	4,492 $15,000
Q2 2023 Aug 15, 2023	BUY	$4.56 - $6.02 $9 - $12	2 Added 0.04%	4,488 $25,000
Q1 2023 May 12, 2023	BUY	$4.3 - $6.2 $2,154 - $3,106	501 Added 12.57%	4,486 $21,000
Q4 2022 Feb 13, 2023	BUY	$4.19 - $6.04 $4 - $6	1 Added 0.03%	3,985 $24,000
Q3 2022 Nov 14, 2022	BUY	$4.59 - $6.5 $936 - $1,326	204 Added 5.4%	3,984 $19,000
Q2 2022 Aug 12, 2022	BUY	$4.82 - $7.45 $1,070 - $1,653	222 Added 6.24%	3,780 $21,000
Q1 2022 May 16, 2022	BUY	$5.6 - $8.22 $13,025 - $19,119	2,326 Added 188.8%	3,558 $25,000
Q4 2021 Feb 14, 2022	BUY	$7.11 - $11.04 $1,983 - $3,080	279 Added 29.28%	1,232 $9,000
Q3 2021 Nov 15, 2021	SELL	$10.53 - $14.93 $68,129 - $96,597	-6,470 Reduced 87.16%	953 $11,000
Q2 2021 Aug 16, 2021	BUY	$12.94 - $19.89 $48,913 - $75,184	3,780 Added 103.76%	7,423 $109,000
Q1 2021 May 13, 2021	BUY	$14.34 - $21.92 $51,265 - $78,364	3,575 Added 5257.35%	3,643 $66,000
Q4 2020 Feb 09, 2021	BUY	$15.1 - $20.69 $860 - $1,179	57 Added 518.18%	68 $1,000
Q3 2020 Nov 05, 2020	BUY	$10.7 - $21.25 $117 - $233	11 New	11 $0

Others Institutions Holding LTRN

# of Institutions

Shares Held

1.27M

Call Options Held

42.8K

Put Options Held

5.6K

View Full List

About Lantern Pharma Inc.

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $35M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

More about LTRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Lantern Pharma Inc. Transaction History